VBI (4170.TWO)

TWD 12.75

(0.0%)

Revenue Summary of VBI

  • VBI's latest annual revenue in 2023 was 55.85 Million TWD , up 30.15% from previous year.
  • VBI's latest quarterly revenue in 2024 Q2 was 11.8 Million TWD , down 0.0% from previous quarter.
  • VBI reported a annual revenue of 42.91 Million TWD in annual revenue 2022, up 49.16% from previous year.
  • VBI reported a annual revenue of 28.77 Million TWD in annual revenue 2021, up 17.22% from previous year.
  • VBI reported a quarterly revenue of 11.8 Million TWD for 2024 Q1, down -20.97% from previous quarter.
  • VBI reported a quarterly revenue of 14.93 Million TWD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of VBI (2023 - 2019)

Historical Annual Revenue of VBI (2023 - 2019)

Year Revenue Revenue Growth
2023 55.85 Million TWD 30.15%
2022 42.91 Million TWD 49.16%
2021 28.77 Million TWD 17.22%
2020 24.54 Million TWD -7.52%
2019 26.54 Million TWD 0.0%

Peer Revenue Comparison of VBI

Name Revenue Revenue Difference
SYN-TECH Chem. & Pharm. Co., Ltd. 1.11 Billion TWD 94.989%
Level Biotechnology Inc. 660.61 Million TWD 91.545%
Sagittarius Life Science Corp 440.46 Million TWD 87.319%
NeoCore Technology Co., Ltd. 64.72 Million TWD 13.713%
GeneReach Biotechnology Corp. 225.46 Million TWD 75.227%
Genomics BioSci & Tech. Co.,Ltd. 396.14 Million TWD 85.901%
Visgeneer Inc. 147.99 Million TWD 62.26%
Sunmax Biotechnology Co., Ltd. 1.68 Billion TWD 96.693%
G&E Herbal Biotechnology Co., Ltd. 181.44 Million TWD 69.217%
Neith Corporation 39.9 Million TWD -39.972%
TaiwanJ Pharmaceuticals Co., Ltd. 22.74 Million TWD -145.594%
Enimmune corporation 43.49 Million TWD -28.415%
TaiRx, Inc. 5.08 Million TWD -999.036%
EirGenix Inc. 1.02 Billion TWD 94.538%
BioLASCO Taiwan Co., Ltd. 264.72 Million TWD 78.901%
Sunny Pharmtech Inc. 428.82 Million TWD 86.975%
Advagene Biopharma Co., Ltd. - TWD -Infinity%
BioGend Therapeutics Co., Ltd. 109.9 Million TWD 49.182%
Feng Chi Biotech Corp. 180.57 Million TWD 69.07%
Lukas Biomedical Inc. 231.83 Million TWD 75.908%
RBC Bioscience Corporation 172.46 Million TWD 67.615%
BiOptic Inc. 228.26 Million TWD 75.532%
Anti-Microbial Savior BioteQ Co., Ltd 728 Thousand TWD -7572.115%
Shine-On BioMedical Co.,Ltd. 9.52 Million TWD -486.445%
Great Novel Therapeutics Biotech & Medicals 4.85 Million TWD -1051.608%
Syngen Biotech Co.,Ltd. 1.83 Billion TWD 96.96%
Mycenax Biotech Inc. 652.62 Million TWD 91.442%
Medigen Vaccine Biologics Corporation 389.62 Million TWD 85.665%
Bio Preventive Medicine Corp. 1.2 Million TWD -4523.593%
TaiMed Biologics Inc. 491.77 Million TWD 88.643%
GlycoNex Incorporation 2.54 Million TWD -2097.207%
Taiwan Advance Bio-Pharmaceutical Inc. 315.98 Million TWD 82.324%
SynCore Biotechnology Co.,Ltd 20.19 Million TWD -176.555%
Lin BioScience, Inc. - TWD -Infinity%
BRIM Biotechnology, Inc. 90 Thousand TWD -61958.889%
CHO Pharma, Inc. - TWD -Infinity%
NaviFUS Corp. 22.48 Million TWD -148.445%
Gwo Xi Stem Cell Applied Technology Co. , Ltd 141.17 Million TWD 60.437%
Sinew Pharma Inc. - TWD -Infinity%
Andros Pharmaceuticals Co.,Ltd 805 Thousand TWD -6838.261%
Greenyn Biotechnology Co., Ltd 800.51 Million TWD 93.023%
Lumosa Therapeutics Co., Ltd. 56.91 Million TWD 1.868%
AP Biosciences Inc 32.25 Million TWD -73.171%
Medigen Biotechnology Corp. 1.15 Billion TWD 95.176%
3D Global Biotech Inc. 20.63 Million TWD -170.697%
Pharmosa Biopharm Inc. 314.5 Million TWD 82.241%
Intech Biopharm Corporation 25.84 Million TWD -116.091%
Oneness Biotech Co., Ltd. 86.78 Million TWD 35.641%
Eusol Biotech Co.,Ltd. - TWD -Infinity%
TWi Biotechnology, Inc. - TWD -Infinity%
Ever Supreme Bio Technology Co., Ltd 758.39 Million TWD 92.635%
TCI GENE Inc. 333.85 Million TWD 83.27%
MegaPro Biomedical Co., Ltd 18 Thousand TWD -310194.444%
Senhwa Biosciences, Inc. 1 Million TWD -5485.3%
Taiwan Bio Therapeutics Co., Ltd 85.47 Million TWD 34.652%
NatureWise Biotech & Medicals Corporation 160.14 Million TWD 65.123%
PharmaEngine, Inc. 767.66 Million TWD 92.724%
Savior Lifetec Corporation 1.05 Billion TWD 94.682%
TaiGen Biopharmaceuticals Holdings Limited 123.13 Million TWD 54.64%
OBI Pharma, Inc. 41.54 Million TWD -34.427%
Meribank Biotech Co., Ltd 234.34 Million TWD 76.166%
Acepodia, Inc. 16.59 Million TWD -236.606%
Caliway Biopharmaceuticals Co., Ltd. 38.93 Million TWD -43.463%